Kineret 100 MG/0.67 ML syringe 0.67ML
Ended Awarded
- Contract number
- SPE2DB26FL5Q2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,162
Award facts
- Contract value 100% obligated
- $7,161.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,161.76 to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Kineret (anakinra) 100 mg/0.67 mL syringes. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance will be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 3, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs across the Defense Logistics Agency's Medical Supply Chain. Kineret is a biologic immunosuppressant used in the treatment of rheumatoid arthritis and other inflammatory conditions, supporting the Department of Defense's healthcare requirements for active-duty personnel, veterans, and military beneficiaries. The company's comprehensive IDC enables flexible sourcing of a broad range of pharmaceutical products and medical supplies globally, positioning AmerisourceBergen to meet diverse military healthcare needs across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FL5Q2?
SPE2DB26FL5Q2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DB26FL5Q2 worth?
The government has obligated $7,162 on SPE2DB26FL5Q2.
Is contract SPE2DB26FL5Q2 an order under another contract?
Yes. SPE2DB26FL5Q2 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB26FL5Q2 competed?
The extent of competition for SPE2DB26FL5Q2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award